Hepatitis B vaccine - Intercell/SciGen

Drug Profile

Hepatitis B vaccine - Intercell/SciGen

Alternative Names: HBV vaccine - Intercell/SciGen; Therapeutic hepatitis B vaccine - Intercell/SciGen

Latest Information Update: 24 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Intercell; SciGen
  • Class Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis B

Most Recent Events

  • 13 Nov 2006 Discontinued - Preclinical for Hepatitis B treatment in Austria (unspecified route)
  • 13 Nov 2006 Discontinued - Preclinical for Hepatitis B treatment in Singapore (unspecified route)
  • 13 Dec 2004 Preclinical trials in Hepatitis B treatment in Austria (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top